1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Belarus Pharmaceuticals and Healthcare Report Q3 2016

Belarus Pharmaceuticals and Healthcare Report Q3 2016

  • May 2016
  • -
  • Business Monitor International
  • -
  • 74 pages

Includes 3 FREE quarterly updates

BMI View: Belarus poses challenges for multinational drugmakers given government initiatives to reducethe reliance on medicinal imports. The weak ruble has seen prices of foreign medicines rise to unaffordablelevels and has led to state intervention in the form of domestic bias in the medicine tendering process,pricing controls and initiatives to boost the domestic drug-making industry. The poor economic outlookfurther deepens the risk to revenue earning opportunities.Headline Expenditure ProjectionsPharmaceuticals: BYR12,247bn in 2015 (USD770mn) to BYR14,354bn (USD740mn) in 2016; +17.2% inlocal currency terms and -4.0% in US dollar terms. Forecast revised upwards from last quarter.Healthcare: BYR47,930bn (USD3.00bn) in 2015 to BYR52,246bn (USD2.68bn) in 2016; +9.0% in localcurrency terms and -10.7% in US dollar terms. Forecast revised downwards from last quarter.

Table Of Contents

Belarus Pharmaceuticals and Healthcare Report Q3 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Belarus 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Belarus 2012-2020) 14
Healthcare Market Forecast 15
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Belarus 2012-2020) 17
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Belarus 2012-2020) 18
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Belarus 2012-2020) 18
Prescription Drug Market Forecast 19
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Belarus 2012-2020) 20
Patented Drug Market Forecast 21
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Belarus 2012-2020) 22
Generic Drug Market Forecast 23
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Belarus 2012-2020) 25
OTC Medicine Market Forecast 26
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Belarus 2012-2020) 28
Pharmaceutical Trade Forecast 29
Table: Pharmaceutical Trade Data And Forecasts (Belarus 2014-2020) 31
Table: Pharmaceutical Trade Data And Forecasts local currency (Belarus 2014-2020) 31
Industry Risk Reward Index 32
Central And Eastern Europe Risk/Reward Index - Q3 2016 32
Belarus Risk/Reward Index 38
Rewards 38
Risks 39
Regulatory Review 40
Intellectual Property Issues 41
Pricing And Reimbursement Regime 43
Market Overview 45
Healthcare Sector 46
Table: Healthcare Resources (Belarus 2010-2015) 49
Table: Healthcare Personnel (Belarus 2010-2015) 49
Table: Healthcare Activity (Belarus 2010-2015) 50
Research And Development 50
Clinical Trials 51
Epidemiology 52
Competitive Landscape 56
Research-Based Industry 56
Table: Multinational Market Activity 57
Generic Drugmakers 57
Pharmaceutical Distribution 59
Pharmaceutical Retail Sector 59
Company Profile 60
Lekpharm 60
Demographic Forecast 63
Demographic Outlook 63
Table: Population Headline Indicators (Belarus 1990-2025) 64
Table: Key Population Ratios (Belarus 1990-2025) 64
Table: Urban/Rural Population and Life Expectancy (Belarus 1990-2025) 65
Table: Population By Age Group (Belarus 1990-2025) 65
Table: Population By Age Group % (Belarus 1990-2025) 66
Glossary 68
Methodology 70
Pharmaceutical Expenditure Forecast Model 70
Healthcare Expenditure Forecast Model 70
Notes On Methodology 71
Risk/Reward Index Methodology 72
Index Overview 73
Table: Pharmaceutical Risk/Reward Index Indicators 73
Indicator Weightings 74

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Prostate Cancer Pricing, Reimbursement, and Access

Prostate Cancer Pricing, Reimbursement, and Access

  • $ 7 500
  • Industry report
  • July 2016
  • by Datamonitor Healthcare

Novel antiandrogens will need to present risk-sharing agreements in EU markets, while discussing contracting with US payers to ensure a competitive advantage. Vaccines suffer from inconclusive response ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7 000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

IMS World Review Executive™ 2016

IMS World Review Executive™ 2016

  • $ 6 860
  • Industry report
  • July 2016
  • by IMS Health

IMS World Review ExecutiveTM 2016 provides essential insights into worldwide sales of the pharmaceutical market, interlocking market trends and sales analysis from 2011 to 2015, including the breakdown ...


Download Unlimited Documents from Trusted Public Sources

Generic Drug Industry in the US

  • September 2016
    9 pages
  • Generic Drug  

  • United States  

View report >

Opioid and Therapy Market in the US

  • September 2016
    11 pages
  • Opioid  

    Therapy  

    Analgesic  

  • United States  

View report >

Opioid Market in the US

  • September 2016
    13 pages
  • Opioid  

    Anesthetics  

    Analgesic  

  • United States  

View report >

Related Market Segments :

Pharmaceutical
Healthcare

ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.